These results suggest that HSPA5 targets to HSPA1A; HA15 can regulate the differentiation and function of Tregs, improve intestinal inflammation in mice with ulcerative colitis, and provide a new therapeutic strategy for clinical treatment. Here, HSPA5 is linked to ulcerative colitis.